Cardlytics (NASDAQ:CDLX – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18, Briefing.com reports. The company had revenue of $67.06 million for the quarter, compared to the consensus estimate of $57.77 million. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The firm’s quarterly revenue was down 15.1% compared to the same quarter last year. During the same period last year, the company posted ($0.26) EPS. Cardlytics updated its Q4 2024 guidance to EPS.
Cardlytics Trading Up 7.4 %
Shares of Cardlytics stock traded up $0.30 during midday trading on Friday, reaching $4.37. The company had a trading volume of 1,752,101 shares, compared to its average volume of 1,242,283. The stock has a fifty day moving average price of $3.69 and a 200 day moving average price of $6.70. Cardlytics has a fifty-two week low of $2.89 and a fifty-two week high of $20.52. The firm has a market cap of $217.80 million, a PE ratio of -1.14 and a beta of 1.61. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.77 and a quick ratio of 1.77.
Analyst Upgrades and Downgrades
CDLX has been the topic of a number of research analyst reports. Evercore ISI started coverage on shares of Cardlytics in a research report on Friday, October 11th. They issued an “in-line” rating and a $4.00 target price on the stock. Northland Capmk lowered Cardlytics from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 16th. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday. Bank of America lowered Cardlytics from a “neutral” rating to an “underperform” rating and cut their price target for the company from $4.00 to $3.50 in a research note on Thursday, August 15th. Finally, Lake Street Capital downgraded Cardlytics from a “buy” rating to a “hold” rating and lowered their price objective for the company from $18.00 to $5.00 in a research note on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Cardlytics presently has a consensus rating of “Hold” and an average target price of $6.92.
Insider Buying and Selling at Cardlytics
In other Cardlytics news, CEO Amit Gupta sold 22,607 shares of the stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the completion of the sale, the chief executive officer now directly owns 178,519 shares in the company, valued at approximately $687,298.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Scott A. Hill acquired 40,000 shares of Cardlytics stock in a transaction dated Monday, August 12th. The stock was bought at an average price of $3.58 per share, with a total value of $143,200.00. Following the transaction, the director now directly owns 40,000 shares in the company, valued at $143,200. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Amit Gupta sold 22,607 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the transaction, the chief executive officer now directly owns 178,519 shares in the company, valued at approximately $687,298.15. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,573 shares of company stock valued at $151,612. 4.40% of the stock is currently owned by company insiders.
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Stories
- Five stocks we like better than Cardlytics
- Health Care Stocks Explained: Why You Might Want to Invest
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- What Does a Stock Split Mean?
- MarketBeat Week in Review – 11/4 – 11/8
- NYSE Stocks Give Investors a Variety of Quality Options
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.